专利检索 ap:("Andrew G. Cole" OR "Ian Henderson" OR "Marc-Raleigh Brescia" OR "Axel Metzger" OR "Lan-Ying Qin" OR "Gulzar Ahmed" OR "Brian F. McGuinness" OR "Yuefei Shao" OR "Jingqi Duo") AND inv:"Lan-Ying Qin" 第 1 页

1.

发明申请
Purinone derivatives for treating neurodegenerative diseases 审中-公开
标题翻译：用于治疗神经变性疾病的朊蛋白衍生物

公开(公告)号：US20090023723A1

公开(公告)日：2009-01-22

申请号：US11534096

申请日：2006-09-21

申请人： Andrew G. Cole , Ian Henderson , Marc-Raleigh Brescia , Axel Metzger , Lan-Ying Qin , Gulzar Ahmed , Brian F. McGuinness , Yuefei Shao , Jingqi Duo

发明人： Andrew G. Cole , Ian Henderson , Marc-Raleigh Brescia , Axel Metzger , Lan-Ying Qin , Gulzar Ahmed , Brian F. McGuinness , Yuefei Shao , Jingqi Duo

IPC分类号： A61K31/522 , C07D413/14 , C07D473/32 , A61P25/00 , A61K31/5377

CPC分类号： C07D473/28 , C07D473/32

摘要： The invention relates to purinone derivatives useful in treating disorders that are mediated by adenosine receptor function, including neurodegenerative diseases and inflammation. The compounds are of the general formula: An example is:

摘要翻译： 本发明涉及可用于治疗由腺苷受体功能介导的疾病（包括神经变性疾病和炎症）的嘌呤酮衍生物。化合物具有以下通式：一个例子是：